跳至主要内容
临床试验/NCT03900897
NCT03900897已完成不适用

Expanded Indications in the MED-EL Pediatric Cochlear Implant Population

Med-El Corporation16 个研究点 分布在 1 个国家目标入组 247 人开始时间: 2019年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
247
试验地点
16
主要终点
Percent correct on Multisyllabic Lexical Neighborhood Test (MLNT)/Lexical Neighborhood Test (LNT)

研究概览

简要总结

The purpose of this investigation is to demonstrate the safety and effectiveness of MED-EL cochlear implants in children 7 months to 5 years, 11 months of age who fall outside the current FDA-approved candidacy criteria and, yet, continue to demonstrate insufficient functional access to sound with appropriately fit hearing aids and aural habilitation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
7 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children 7 months to 5 years 11 months of age at the time of implantation
  • Bilateral, severe to profound sensorineural hearing loss (SNHL) in the high frequencies and
  • For subjects implanted under 12 months of age: bilateral, severe to profound SNHL in the low frequencies
  • For subjects implanted at 12 months to 5 years 11 months of age: bilateral, mild to profound sensorineural hearing loss in the low frequencies
  • Insufficient functional access to sound with appropriately fit amplification and aural habilitation
  • Objective measures consistent with repeatable unaided audiometric thresholds for subjects under 12 months of age
  • Radiologic evidence of potential for full insertion with one of the included electrode arrays
  • Ability to undergo general anesthesia
  • At least one parent/guardian who is fluent in one of the available languages of the LEAQ
  • Parental commitment to study parameters

排除标准

  • Magnetic Resonance Imaging (MRI) evidence of cochlear nerve deficiency
  • Active middle ear infection
  • Permanent conductive hearing loss
  • Treatable mixed hearing loss
  • Current or history of meningitis
  • Common cavity
  • Skin or scalp condition precluding use of external audio processor
  • Suspected cognitive impairment, organic brain dysfunction, or syndromic etiology that may affect performance
  • ASA (American Society of Anesthesiologists) Class 3 or higher in subjects under 12 months of age
  • History of prior use of a hearing implant
  • Unrealistic parental/patient expectations
  • Child is not able to complete speech perception testing in English

结局指标

主要结局

Percent correct on Multisyllabic Lexical Neighborhood Test (MLNT)/Lexical Neighborhood Test (LNT)

时间窗: Up to 12 Months Post-Activation

Clinical success defined as an improvement of 10 percentage points or more on MLNT/LNT.

Number and proportion of subjects experiencing device- and/or procedure-related adverse events.

时间窗: Up to 12 Months Post-Activation

Adverse events will be collected and reported throughout the duration of the study.

Total Score on LittlEARS Auditory Questionnaire (LEAQ)

时间窗: Up to 12 Months Post-Activation

Clinical success defined as a Total Score of 25 or more on the LittLEARS Auditory Questionnaire (LEAQ). Total Score ranges from zero to 35, with higher scores indicating development of increasingly complex listening skills.

次要结局

  • Total Score on Auditory Skills Checklist (ASC)(Up to 12 Months Post-Activation)
  • Total Score on LittlEARS Auditory Questionnaire (LEAQ)(Up to 12 Months Post-Activation)
  • Speech recognition testing in the implanted ear(s)(Up to 12 Month Post-Activation)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

Expanded Indications in the MED-EL Pediatric... | 临床试验